Pfizer wants to make vaccine in India if faster clearance, export freedom assured: Sources

The U.S. company pulled an application last month seeking emergency approval for its product in India after the drug regulator declined its request to skip a small local safety trial. That has kept its vaccine, developed with Germany's BioNTech SE, out of one of the world's biggest drug markets.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news